Our customers will also benefit from ICON’s access to the industry’s broadest set of COA tools and instruments as well as new and enhanced real world data sets. Mapi has been a pioneer of late ...

Icon has bought health research and commercialization company Mapi for integration into its existing commercialization team, a deal that bumped Icon’s whole-year revenue guidance to $1.77 billion o ...

Clinical research firm ICON has announced the acquisition of Mapi Group, a health outcomes research and commercialisation company with around 750 employees in 12 countries. The deal makes ICON the ...

ICON has invested significantly in its AI and digital capabilities through the establishment of its AI Centre of Excellence. The centre, which comprises a dedicated team of data scientists ...